{"@id":"https://bioecon.ru/technology/eclinical-platforms/","@type":"Technology","cluster":"digital-it","formats":{"html":"https://cn.bioecon.ru/technology/eclinical-platforms/","json":"https://cn.bioecon.ru/api/v1/technology/eclinical-platforms/index.json"},"id":"eclinical-platforms","industries":["digital-robotics","bio-ai","pharma","services"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/digital-robotics/","https://bioecon.ru/industries/bio-ai/","https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/services/"],"suppliers":["https://bioecon.ru/companies/biohalo-aps/","https://bioecon.ru/companies/bluepha/","https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/recursion-pharmaceuticals/","https://bioecon.ru/companies/kukdo-chemical/","https://bioecon.ru/companies/yara/","https://bioecon.ru/companies/shin-etsu-chemical/","https://bioecon.ru/companies/nissan-chemical/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/shengquan-group/","https://bioecon.ru/companies/relicta-srl/"]},"maturity":9,"name":"一体化全栈数字临床试验平台：eCOA/eConsent/EDC/CTMS/eTMF统一协同生态","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"services-governance-capital","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"统一数据底座与全局元数据模型部署"},{"n":2,"title":"受试者中心化多媒体eConsent与移动BYOD ePRO"},{"n":3,"title":"基于风险的质量监控（RBQM）与CTMS中心化监查"},{"n":4,"title":"随时应对监管飞行核查的智能化eTMF自动归档"}],"summary":"打破传统临床试验数据孤岛的一体化全栈式eClinical云生态平台。平台采用统一底层单数据源（Single Source of Truth）架构，原生深度整合电子患者临床结局评估（eCOA/ePRO移动端应用）、多媒体交互式知情同意（eConsent）、电子数据采集（EDC）、临床试验管理中枢（CTMS）及数字化试验主文档（eTMF），实现从受试者指尖上报到监管核查的一键穿透式全流程无缝流转与实时质量管控。","url":"/technology/eclinical-platforms/","verified":"2026-11-22"}